Logo image of GH

GUARDANT HEALTH INC (GH) Stock Analyst Ratings

NASDAQ:GH - Nasdaq - US40131M1099 - Common Stock - Currency: USD

47.595  +0.42 (+0.9%)

After market: 47.595 0 (0%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to GH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 45.75. This target is -3.87% below the current price.
GH was analyzed by 31 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about GH.
In the previous month the buy percentage consensus was at a similar level.
GH was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
GH Historical Analyst RatingsGH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -74 -67 -60 -53 -46 -39 -32 -25 -18 -11 -4 10 20 30

Price Target & Forecast

Price Low Median Mean High 47.6020.2045.9045.7563.00 - -57.56% -3.56% -3.87% 32.37%
GH Current Analyst RatingGH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10
Up and Down Grades
Date Firm Action Rating
2025-01-28 Goldman Sachs Maintains Buy -> Buy
2025-01-23 Barclays Initiate Overweight
2025-01-22 Guggenheim Reiterate Buy -> Buy
2024-11-07 JP Morgan Maintains Overweight -> Overweight
2024-11-07 Goldman Sachs Maintains Buy -> Buy
2024-10-30 Bernstein Maintains Outperform -> Outperform
2024-10-17 Leerink Partners Maintains Outperform -> Outperform
2024-08-21 UBS Maintains Buy -> Buy
2024-08-13 Piper Sandler Maintains Overweight -> Overweight
2024-08-08 TD Cowen Maintains Buy -> Buy
2024-08-08 JP Morgan Maintains Overweight -> Overweight
2024-08-08 Craig-Hallum Maintains Buy -> Buy
2024-08-08 Citigroup Maintains Buy -> Buy
2024-07-30 BTIG Maintains Buy -> Buy
2024-07-18 B of A Securities Maintains Buy -> Buy
2024-07-17 Goldman Sachs Maintains Buy -> Buy
2024-06-28 Guggenheim Upgrade Neutral -> Buy
2024-06-04 Canaccord Genuity Maintains Buy -> Buy
2024-06-03 Jefferies Initiate Buy
2024-05-24 Stephens & Co. Reiterate Overweight -> Overweight
2024-04-29 Canaccord Genuity Maintains Buy -> Buy
2024-04-15 Goldman Sachs Maintains Buy -> Buy
2024-04-05 Guggenheim Reiterate Neutral
2024-02-26 Piper Sandler Maintains Overweight -> Overweight
2024-02-23 JP Morgan Maintains Overweight -> Overweight
2024-02-23 Canaccord Genuity Maintains Buy -> Buy
2024-01-30 Goldman Sachs Maintains Buy -> Buy
2024-01-29 Goldman Sachs Maintains Buy -> Buy
2023-12-14 Guggenheim Initiate Neutral
2023-12-13 Wolfe Research Initiate Peer Perform